Literature DB >> 16135091

Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.

Jie Li1, Carsten Scheller, Eleni Koutsilieri, Francine Griffiths, Philip M Beart, Linda D Mercer, Glenda Halliday, Emma Kettle, Dominic Rowe, Peter Riederer, Manfred Gerlach, Michael Rodriguez, Kay L Double.   

Abstract

We investigated the effects of neuromelanin (NM) isolated from the human substantia nigra and synthetic dopamine melanin (DAM) on neuronal and glial cell lines and on primary rat mesencephalic cultures. Lactate dehydrogenase (LDH) activity and lipid peroxidation were significantly increased in SK-N-SH cells by DAM but not by NM. In contrast, iron-saturated NM significantly increased LDH activity in SK-N-SH cells, compared with 100 mg/mL ETDA-treated NM containing a low concentration of bound iron. DAM, but not NM, stimulated hydroxyl radical production and increased SK-N-SH cell death via apoptotic-like mechanisms. Neither DAM nor NM induced any changes in the glial cell line U373. 3H-dopamine uptake in primary rat mesencephalic cultures was significantly reduced in DAM-compared with NM-treated cultures, accompanied by increased cell death via an apoptosis-like mechanism. Interestingly, Fenton-induced cell death was significantly decreased in cultures treated with both Fenton reagent and NM, an effect not seen in cultures treated with Fenton reagent plus DAM. These data are suggestive of a protective role for neuromelanin under conditions of high oxidative load. Our findings provide new evidence for a physiological role for neuromelanin in vivo and highlights the caution with which data based upon model systems should be interpreted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135091     DOI: 10.1111/j.1471-4159.2005.03404.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Functional effects of neuromelanin and synthetic melanin in model systems.

Authors:  K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

2.  Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells.

Authors:  Jie Li; Junfeng Yang; Peng Zhao; Shen Li; Renyun Zhang; Xiaobin Zhang; Dan Liu; Benshu Zhang
Journal:  J Neural Transm (Vienna)       Date:  2011-12-27       Impact factor: 3.575

3.  A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.

Authors:  Pier Giorgio Mastroberardino; Eric K Hoffman; Maxx P Horowitz; Ranjita Betarbet; Georgia Taylor; Dongmei Cheng; Hye Mee Na; Claire-Anne Gutekunst; Marla Gearing; John Q Trojanowski; Marjorie Anderson; Charleen T Chu; Junmin Peng; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-02-26       Impact factor: 5.996

4.  Differential effects of dopamine melanin on norharman-induced toxicity in PC12 cells.

Authors:  A Ostergren; N G Lindquist; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2007-01-28       Impact factor: 3.850

5.  Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.

Authors:  Matthias Elstner; Sarina K Müller; Lars Leidolt; Christoph Laub; Lena Krieg; Falk Schlaudraff; Birgit Liss; Chris Morris; Douglass M Turnbull; Eliezer Masliah; Holger Prokisch; Thomas Klopstock; Andreas Bender
Journal:  Mol Brain       Date:  2011-12-21       Impact factor: 4.041

6.  Neuromelanin is an immune stimulator for dendritic cells in vitro.

Authors:  Uwe Oberländer; Katrien Pletinckx; Anja Döhler; Nora Müller; Manfred B Lutz; Thomas Arzberger; Peter Riederer; Manfred Gerlach; Eleni Koutsilieri; Carsten Scheller
Journal:  BMC Neurosci       Date:  2011-11-15       Impact factor: 3.288

Review 7.  A brief history of brain iron accumulation in Parkinson disease and related disorders.

Authors:  Paul B Foley; Dominic J Hare; Kay L Double
Journal:  J Neural Transm (Vienna)       Date:  2022-05-09       Impact factor: 3.850

Review 8.  Oxidative stress and Parkinson's disease.

Authors:  Javier Blesa; Ines Trigo-Damas; Anna Quiroga-Varela; Vernice R Jackson-Lewis
Journal:  Front Neuroanat       Date:  2015-07-08       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.